We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Regions of Unstable Non-Coding DNA Pose Potential Health Risk

By LabMedica International staff writers
Posted on 15 Sep 2016
Genomics researchers have found that variation within the highly repetitive, non-coding DNA of human centromere satellite DNA regions has a pronounced impact on genome stability and basic chromosomal function that have ramifications regarding the health of the individual.

Satellite DNA, the main component of functional centromeres and of heterochromatin consists of very large arrays of tandem repeating, non-coding DNA. More...
The name "satellite DNA" refers to how repetitions of a short DNA sequence tend to produce a different frequency of the nucleotides adenine, cytosine, guanine, and thymine, and thus have a different density from bulk DNA - such that they form a second or "satellite" band when genomic DNA is separated on a density gradient.

A defined number of 171 base pair monomers are organized into chromosome-specific higher order repeats (HORs) that are repeated thousands of times. At least half of all human chromosomes have two or more distinct HOR alpha satellite arrays within their centromere regions. These regions can affect the stability of the genome and the proper function of the chromosomes, leading to an increased risk of cancer, birth defects, and infertility.

Investigators at Duke University (Durham, NC, USA) previously showed that the two alpha satellite arrays of Homo sapiens chromosome 17 (HSA17), D17Z1 and D17Z1-B, behaved as centromeric epialleles, that is, the centromere, defined by chromatin containing the centromeric histone variant CENPA and recruitment of other centromere proteins, could form at either D17Z1 or D17Z1-B. Some individuals in the human population are functional heterozygotes in that D17Z1 is the active centromere on one homolog and D17Z1-B is active on the other.

In the current study, the investigators aimed at understanding the molecular basis for how centromere location was determined on HSA17. Specifically, they focused on D17Z1 genomic variation as a driver of epiallele formation.

They reported in the August 10, 2016, online edition of the journal Genome Research that D17Z1 arrays that were predominantly composed of HOR size and sequence variants were functionally less competent. These arrays either recruited decreased amounts of the centromere-specific histone variant CENPA and the HSA17 was mitotically unstable, or alternatively, the centromere was assembled at D17Z1-B and the HSA17 was stable.

This study demonstrated that genomic variation within highly repetitive, non-coding DNA of human centromere regions had a pronounced impact on genome stability and basic chromosomal function.

"Variation is not only important for how genes and proteins function, but it can also occur in the noncoding, repetitive portions of the genome," said senior author Dr. Elizabeth Sullivan, associate professor of molecular biology and microbiology at Duke University. "What we found in this study is probably the tip of the iceberg. There could be all sorts of functional consequences to having variation within the complex, repetitive portion of the genome that we do not know about yet."

"It is immensely fascinating to think that there are so many people walking around who are essentially centromere mosaics," said Dr. Sullivan. "One of their centromeres, on one of their chromosomes, has the potential to be dangerously unstable, and it could affect their ability to reproduce, or predispose them to cancer."

Related Links:
Duke University


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.